Taiyo Pharmaceutical Voluntarily Recalls 112.8 Million Injectables
This article was originally published in PharmAsia News
Executive Summary
Nagoya-based Taiyo Pharmaceutical announced a recall Jan. 13 in the Japanese market for pain reliever Nolport (extract of vaccinated rabbit skin) injections